Ofatumumab-associated acute respiratory manifestations: clinical characteristics and treatment

被引：7

作者：

Bonanni, Alice ^{[1
]}

Bertelli, Enrica ^{[1
]}

Moscatelli, Andrea ^{[2
]}

Lampugnani, Elisabetta ^{[2
]}

Bodria, Monica ^{[1
]}

Ravani, Pietro ^{[3
]}

Ghiggeri, Gian Marco ^{[1
]}

机构：

[1] Giannina Gaslini Childrens Hosp, Div Nephrol, Dialysis, Transplantat, Via Gerolamo Gaslini 5, I-16148 Genoa, Italy

[2] Giannina Gaslini Childrens Hosp, Dept Crit Care & Perinatal Med, Neonatal & Pediat ICU, I-16148 Genoa, Italy

[3] Univ Calgary, Div Nephrol, Calgary, AB T2N 2T9, Canada

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2016年 / 82卷 / 04期

关键词：

ANTIBODY; TRIAL;

D O I：

10.1111/bcp.13029

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1146 / 1148

页数：3

共 7 条

[1] Ofatumumab for Rituximab- Resistant Nephrotic Syndrome [J].

Basu, Biswanath .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13) :1268-1270

[2] Regulatory T cells and minimal change nephropathy: in the midst of a complex network [J].

Bertelli, R. ;

Bonanni, A. ;

Di Donato, A. ;

Cioni, M. ;

Ravani, P. ;

Ghiggeri, G. M. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 183 (02) :166-174

[3]

Bonanni Alice, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-210208

[4] Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20 [J].

Du, Jiamu ;

Yang, Hui ;

Guo, Yajun ;

Ding, Jianping .

MOLECULAR IMMUNOLOGY, 2009, 46 (11-12) :2419-2423

[5] Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma - a phase II trial [J].

Furtado, Michelle ;

Dyer, Martin J. S. ;

Johnson, Rod ;

Berrow, Margie ;

Rule, Simon .

BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (04) :575-578

[6] Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis A phase 2 study [J].

Sorensen, Per S. ;

Lisby, Steen ;

Grove, Richard ;

Derosier, Frederick ;

Shackelford, Steve ;

Havrdova, Eva ;

Drulovic, Jelena ;

Filippi, Massimo .

NEUROLOGY, 2014, 82 (07) :573-581

[7] Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial [J].

Taylor, Peter C. ;

Quattrocchi, Emilia ;

Mallett, Stephen ;

Kurrasch, Regina ;

Petersen, Jorgen ;

Chang, David J. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (12) :2119-2125

← 1 →